164 related articles for article (PubMed ID: 30196018)
1. T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice.
Xu J; Yabuki Y; Yu M; Fukunaga K
J Pharmacol Sci; 2018 Aug; 137(4):333-341. PubMed ID: 30196018
[TBL] [Abstract][Full Text] [Related]
2. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice.
Yuan D; Cheng A; Kawahata I; Izumi H; Xu J; Fukunaga K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451040
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of SAK3, a novel T-type voltage-gated Ca
Yabuki Y; Matsuo K; Izumi H; Haga H; Yoshida T; Wakamori M; Kakei A; Sakimura K; Fukuda T; Fukunaga K
Neuropharmacology; 2017 May; 117():1-13. PubMed ID: 28093211
[TBL] [Abstract][Full Text] [Related]
4. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation.
Yabuki Y; Jing X; Fukunaga K
Neurochem Int; 2017 Sep; 108():272-281. PubMed ID: 28457878
[TBL] [Abstract][Full Text] [Related]
5. T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice.
Wang S; Yabuki Y; Matsuo K; Xu J; Izumi H; Sakimura K; Saito T; Saido TC; Fukunaga K
PLoS One; 2018; 13(12):e0206986. PubMed ID: 30571684
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice.
Moriguchi S; Shinoda Y; Yamamoto Y; Sasaki Y; Miyajima K; Tagashira H; Fukunaga K
PLoS One; 2013; 8(4):e60863. PubMed ID: 23593332
[TBL] [Abstract][Full Text] [Related]
7. Acute Treatment with T-Type Calcium Channel Enhancer SAK3 Reduces Cognitive Impairments Caused by Methimazole-Induced Hypothyroidism Via Activation of Cholinergic Signaling.
Husain N; Yabuki Y; Shinoda Y; Fukunaga K
Pharmacology; 2018; 101(5-6):309-321. PubMed ID: 29597200
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency.
Dhanalakshmi C; Janakiraman U; Moutal A; Fukunaga K; Khanna R; Nelson MA
Neurobiol Dis; 2021 Feb; 149():105224. PubMed ID: 33359140
[TBL] [Abstract][Full Text] [Related]
9. T-Type Ca
Xu J; Kawahata I; Izumi H; Fukunaga K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201181
[TBL] [Abstract][Full Text] [Related]
10. A novel cognitive enhancer, ZSET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice.
Shioda N; Yamamoto Y; Han F; Moriguchi S; Yamaguchi Y; Hino M; Fukunaga K
J Pharmacol Exp Ther; 2010 Apr; 333(1):43-50. PubMed ID: 20068029
[TBL] [Abstract][Full Text] [Related]
11. The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome.
Janakiraman U; Dhanalakshmi C; Yu J; Moutal A; Boinon L; Fukunaga K; Khanna R; Nelson MA
Neurobiol Dis; 2020 Sep; 143():105006. PubMed ID: 32622085
[TBL] [Abstract][Full Text] [Related]
12. [Role of T-type Calcium Channels in Regulating Neuronal Function].
Yabuki Y
Yakugaku Zasshi; 2020; 140(10):1207-1212. PubMed ID: 32999199
[TBL] [Abstract][Full Text] [Related]
13. SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App
Izumi H; Kawahata I; Shinoda Y; Helmstetter FJ; Fukunaga K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481611
[TBL] [Abstract][Full Text] [Related]
14. Memantine Improves Depressive-like Behaviors via Kir6.1 Channel Inhibition in Olfactory Bulbectomized Mice.
Moriguchi S; Inagaki R; Shimojo H; Sugimura Y; Fukunaga K
Neuroscience; 2020 Aug; 442():264-273. PubMed ID: 32531473
[TBL] [Abstract][Full Text] [Related]
15. T-type Ca
Degawa T; Kawahata I; Izumi H; Shinoda Y; Fukunaga K
J Pharmacol Sci; 2021 May; 146(1):1-9. PubMed ID: 33858649
[TBL] [Abstract][Full Text] [Related]
16. Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice.
Han F; Nakano T; Yamamoto Y; Shioda N; Lu YM; Fukunaga K
Brain Res; 2009 Apr; 1265():205-14. PubMed ID: 19233146
[TBL] [Abstract][Full Text] [Related]
17. Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice.
Moriguchi S; Tanaka T; Tagashira H; Narahashi T; Fukunaga K
Behav Brain Res; 2013 Apr; 242():150-7. PubMed ID: 23295391
[TBL] [Abstract][Full Text] [Related]
18. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus.
Han F; Shioda N; Moriguchi S; Yamamoto Y; Raie AY; Yamaguchi Y; Hino M; Fukunaga K
J Pharmacol Exp Ther; 2008 Jul; 326(1):127-34. PubMed ID: 18388258
[TBL] [Abstract][Full Text] [Related]
19. BE360, a new selective estrogen receptor modulator, produces antidepressant and antidementia effects through the enhancement of hippocampal cell proliferation in olfactory bulbectomized mice.
Nakagawasai O; Nemoto W; Onogi H; Moriya T; Lin JR; Odaira T; Yaoita F; Ogawa T; Ohta K; Endo Y; Tan-No K
Behav Brain Res; 2016 Jan; 297():315-22. PubMed ID: 26497104
[TBL] [Abstract][Full Text] [Related]
20. [Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior].
Shioda N; Yamamoto Y; Han F; Moriguchi S; Fukunaga K
Yakugaku Zasshi; 2011 Apr; 131(4):505-11. PubMed ID: 21467789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
